Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Randomized Clinical Trial, Placebo-controlled to Assess the Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: E-SPERANZA COVID-19 PROJECT

NCT04695704 is registered in ClinicalTrials.gov with Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina as lead sponsor.

NCT NCT04695704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04695704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Randomized Clinical Trial, Placebo-controlled to Assess the Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: E-SPERANZA COVID-19 PROJECT
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Phase
Phase 3
Overall status
Terminated
Start date
August 11, 2021
Completion date
August 28, 2023
Enrollment
86 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars (disease)